Retrospective Evaluation of the Efficacy of Total Neoadjuvant Therapy and Chemoradiotherapy Neoadjuvant Treatment in Relation to Surgery in Patients with Rectal Cancer

被引:1
作者
Bratu, Lucian Dragos [1 ,2 ]
Schenker, Michael [2 ,3 ]
Stovicek, Puiu Olivian [2 ,4 ]
Schenker, Ramona Adriana [2 ]
Mehedinteanu, Alina Maria [2 ]
Berisha, Tradian Ciprian [1 ,2 ]
Donoiu, Andreas [1 ,5 ]
Mogoanta, Stelian Stefanita [5 ,6 ]
机构
[1] Univ Med & Pharm Craiova, Doctoral Sch, Craiova 200349, Romania
[2] Sf Nectarie Oncol Ctr, Craiova 200347, Romania
[3] Univ Med & Pharm Craiova, Dept Oncol, Craiova 200349, Romania
[4] Titu Maiorescu Univ, Targu Jiu Subsidiary, Fac Nursing, Dept Pharmacol, Bucharest 040441, Romania
[5] Emergency Cty Hosp, Gen Surg Clin 3, Craiova 200642, Romania
[6] Univ Med & Pharm Craiova, Dept Surg, Craiova 200349, Romania
来源
MEDICINA-LITHUANIA | 2024年 / 60卷 / 04期
关键词
rectal cancer; neoadjuvant therapy; total neoadjuvant therapy; chemoradiotherapy; tumor stage; PREOPERATIVE RADIATION-THERAPY; PATHOLOGICAL COMPLETE RESPONSE; OPEN-LABEL; POSTOPERATIVE CHEMOTHERAPY; GERMAN CAO/ARO/AIO-04; ADJUVANT CHEMOTHERAPY; MESORECTAL EXCISION; OXALIPLATIN; RADIOTHERAPY; TRIAL;
D O I
10.3390/medicina60040656
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background and Objective: In the therapeutic strategy of rectal cancer, radiotherapy has consolidated its important position and frequent use in current practice due to its indications as neoadjuvant, adjuvant, definitive, or palliative treatment. In recent years, total neoadjuvant therapy (TNT) has been established as the preferred regimen compared to concurrent neoadjuvant chemoradiotherapy (CRT). In relation to better outcomes, the percentage of patients who achieved pathological complete response (pCR) after neoadjuvant treatment is higher in the case of TNT. This study aimed to analyze the response to TNT compared to neoadjuvant CRT regarding pCR rate and the change in staging after surgical intervention. Materials and Methods: We performed a retrospective study on 323 patients with rectal cancer and finally analyzed the data of 201 patients with neoadjuvant treatment, selected based on the inclusion and exclusion criteria. Patients received CRT neoadjuvant therapy or TNT neoadjuvant therapy with FOLFOX or CAPEOX. Results: Out of 157 patients who underwent TNT treatment, 19.74% had pathological complete response, whereas in the group with CRT (n = 44), those with pCR were 13.64%. After neoadjuvant treatment, the most frequent TNM classifications were ypT2 (40.30%) and ypN0 (79.10%). The statistical analysis of the postoperative disease stage, after neoadjuvant therapy, showed that the most frequent changes were downstaging (71.14%) and complete response (18.41%). Only four patients (1.99%) had an upstaging change. The majority of patients (88.56%) initially presented clinical evidence of nodal involvement whereas only 20.9% of the patients still presented regional disease at the time of surgical intervention. Conclusions: By using TNT, a higher rate of stage reduction is obtained compared to the neoadjuvant CRT treatment. The post-neoadjuvant-treatment imagistic evaluation fails to accurately evaluate the response. A better response to TNT was observed in young patients.
引用
收藏
页数:15
相关论文
共 54 条
[1]   The evolution of rectal cancer treatment: the journey to total neoadjuvant therapy and organ preservation [J].
Affleck, Arthur ;
Koprowski, Marina Affi ;
Nabavizadeh, Nima ;
Tsikitis, Vassiliki Liana .
ANNALS OF GASTROENTEROLOGY, 2022, 35 (03) :226-233
[2]   Final results from NSABP protocol R-04: Neoadjuvant chemoradiation (RT) comparing continuous infusion (CIV) 5-FU with capecitabine (Cape) with or without oxaliplatin (Ox) in patients with stage II and III rectal cancer. [J].
Allegra, Carmen Joseph ;
Yothers, Greg ;
O'Connell, Michael J. ;
Roh, Mark S. ;
Lopa, Samia H. ;
Petrelli, Nicholas J. ;
Beart, Robert W. ;
Sharif, Saima ;
Wolmark, Norman .
JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
[3]  
American Joint Committee on Cancer (AJCC), 2017, TNM Staging Classification for Rectal Cancer, V8th ed.
[4]   Primary Tumor Response to Preoperative Chemoradiation With or Without Oxaliplatin in Locally Advanced Rectal Cancer: Pathologic Results of the STAR-01 Randomized Phase III Trial [J].
Aschele, Carlo ;
Cionini, Luca ;
Lonardi, Sara ;
Pinto, Carmine ;
Cordio, Stefano ;
Rosati, Gerardo ;
Artale, Salvatore ;
Tagliagambe, Angiolo ;
Ambrosini, Giovanni ;
Rosetti, Paola ;
Bonetti, Andrea ;
Negru, Maria Emanuela ;
Tronconi, Maria Chiara ;
Luppi, Gabriele ;
Silvano, Giovanni ;
Corsi, Domenico Cristiano ;
Bochicchio, Anna Maria ;
Chiaulon, Germana ;
Gallo, Maurizio ;
Boni, Luca .
JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (20) :2773-2780
[5]   Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial [J].
Bahadoer, Renu R. ;
Dijkstra, Esmee A. ;
van Etten, Boudewijn ;
Marijnen, Corrie A. M. ;
Putter, Hein ;
Kranenbarg, Elma Meershoek-Klein ;
Roodvoets, Annet G. H. ;
Nagtegaal, Iris D. ;
Beets-Tan, Regina G. H. ;
Blomqvist, Lennart K. ;
Fokstuen, Tone ;
ten Tije, Albert J. ;
Capdevila, Jaume ;
Hendriks, Mathijs P. ;
Edhemovic, Ibrahim ;
Cervantes, Andres ;
Nilsson, Per J. ;
Glimelius, Bengt ;
van de Velde, Cornelis J. H. ;
Hospers, Geke A. P. .
LANCET ONCOLOGY, 2021, 22 (01) :29-42
[6]   Increasing Disparities in the Age-Related Incidences of Colon and Rectal Cancers in the United States, 1975-2010 [J].
Bailey, Christina E. ;
Hu, Chung-Yuan ;
You, Nancy ;
Bednarski, Brian K. ;
Rodriguez-Bigas, Miguel A. ;
Skibber, John M. ;
Cantor, Scott B. ;
Chang, George J. .
JAMA SURGERY, 2015, 150 (01) :17-22
[7]   Adverse effects of preoperative radiation therapy for rectal cancer:: Long-term follow-up of the Swedish rectal cancer trial [J].
Birgisson, H ;
Påhlman, L ;
Gunnarsson, U ;
Glimelius, B .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (34) :8697-8705
[8]   Is the 1-cm Rule of Distal Bowel Resection Margin in Rectal Cancer Based on Clinical Evidence? A Systematic Review [J].
Bujko, Krzysztof ;
Rutkowski, Andrzej ;
Chang, George J. ;
Michalski, Wojciech ;
Chmielik, Ewa ;
Kusnierz, Jerzy .
ANNALS OF SURGICAL ONCOLOGY, 2012, 19 (03) :801-808
[9]   Prognostic value of pathologic complete response after neoadjuvant therapy in locally advanced rectal cancer: Long-term analysis of 566 ypcr patients [J].
Capirci, Carlo ;
Valentini, Vincenzo ;
Cionini, Luca ;
De Paoli, Antonino ;
Rodel, Claus ;
Glynne-Jones, Robert ;
Coco, Claudio ;
Romano, Mario ;
Mantello, Giovanna ;
Palazzi, Silvia ;
Mattia, Falchetti Osti ;
Friso, Maria Luisa ;
Genovesi, Domenico ;
Vidali, Cristiana ;
Gambacorta, Maria Antonietta ;
Buffoli, Alberto ;
Lupattelli, Marco ;
Favretto, Maria Silvia ;
La Torre, Giuseppe .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 72 (01) :99-107
[10]   Neoadjuvant chemotherapy with FOLFIRINOX and preoperative chemoradiotherapy for patients with locally advanced rectal cancer (UNICANCER-PRODIGE 23) : a multicentre, randomised, open-label, phase 3 trial [J].
Conroy, Thierry ;
Bosset, Jean-Francois ;
Etienne, Pierre-Luc ;
Rio, Emmanuel ;
Francois, Eric ;
Mesgouez-Nebout, Nathalie ;
Vendrely, Veronique ;
Artignan, Xavier ;
Bouche, Olivier ;
Gargot, Dany ;
Boige, Valerie ;
Bonichon-Lamichhane, Nathalie ;
Louvet, Christophe ;
Morand, Clotilde ;
de la Fouchardiere, Christelle ;
Lamfichekh, Najib ;
Juzyna, Beata ;
Jouffroy-Zeller, Claire ;
Rullier, Eric ;
Marchal, Frederic ;
Gourgou, Sophie ;
Castan, Florence ;
Borg, Christophe .
LANCET ONCOLOGY, 2021, 22 (05) :702-715